VivoSim Labs VIVS
NASDAQ VIVS
$0.23 -0.03 (-11.54%)
At close: Sep 18, 2026 · 4:00 PM EDT

VivoSim Labs (VIVS) Change in Accured Expenses (2010 - 2026)

VivoSim Labs (VIVS) posted Change in Accured Expenses of -$243000.0 for Q2 2026, down 249.08% on a QoQ basis from $163000.0 in Q1 2026, and up 51.3% year-over-year from -$160605.3 in Q2 2025.

Analysis

VivoSim Labs (VIVS) Change in Accured Expenses (2010 - 2026) Analysis & Trends

VivoSim Labs has reported Change in Accured Expenses for 17 years, with the latest figure at -$243000.0 in Q2 2026.

  • On a quarterly basis, Change in Accured Expenses rose 51.3% year-over-year to -$243000.0 in Q2 2026; TTM through Jun 2026 was $11000.0, a 97.97% decrease from a year earlier, with the FY2026 full-year figure at -$245000.0, down 134.17% from the prior year.
  • Change in Accured Expenses was -$243000.0 for Q2 2026 at VivoSim Labs, down from $163000.0 in the prior quarter.
  • The five-year high for Change in Accured Expenses was $2.2 million in Q1 2023, with the low at -$2.1 million in Q2 2023.
  • Average Change in Accured Expenses over 5 years is $1764.7, with a median of $47000.0 recorded in 2025.
  • The sharpest annual moves came in 2022 and 2023: Change in Accured Expenses tumbled 2086.36% in 2022, then jumped 603.89% in 2023.
  • Over 5 years, Change in Accured Expenses stood at $184000.0 in 2022, then tumbled by 66.85% to $61000.0 in 2023, then surged by 480.33% to $354000.0 in 2024, then tumbled by 86.72% to $47000.0 in 2025, then slumped by 617.02% to -$243000.0 in 2026.
  • The last three Change in Accured Expenses figures came in at -$243000.0 (Q2 2026), $163000.0 (Q1 2026), and $47000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Iqvia Holdings 43.87 Bn 41.92 Bn 1.44 Bn -
2 Medpace Holdings 17.09 Bn 16.59 Bn 201.64 Mn 45.02 Mn
3 Charles River Laboratories International 13.27 Bn 13.12 Bn 452.07 Mn 18.90 Mn
4 Icon 12.57 Bn 11.64 Bn 479.29 Mn -
5 Fortrea Holdings 1.90 Bn 1.73 Bn 139.20 Mn 25.10 Mn
6 Evotec SE 568.89 Mn 143.02 Mn - -
7 Ginkgo Bioworks Holdings 502.68 Mn 418.15 Mn 18.44 Mn 3.94 Mn
8 Champions Oncology 73.77 Mn 69.94 Mn 7.70 Mn 83,000.00
9 MindWalk Holdings 63.53 Mn 58.06 Mn 1.61 Mn -
10 VivoSim Labs 1.21 Mn 1.21 Mn - -243,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -243,000.00
Mar 31, 2026 163,000.00
Dec 31, 2025 47,000.00
Sep 30, 2025 44,000.00
Jun 30, 2025 -499,000.00
Mar 31, 2025 211,000.00
Dec 31, 2024 354,000.00
Sep 30, 2024 475,000.00
Jun 30, 2024 -323,000.00
Dec 31, 2023 61,000.00
Sep 30, 2023 -121,000.00
Jun 30, 2023 -2.06 Mn
Mar 31, 2023 2.20 Mn
Dec 31, 2022 184,000.00
Sep 30, 2022 -208,000.00
Jun 30, 2022 181,000.00
Mar 31, 2022 -437,000.00
Dec 31, 2021 209,000.00
Sep 30, 2021 330,000.00
Jun 30, 2021 -53,000.00